The administration reported a 7,100% increase in Medicare tissue and organ transplant claims from 2019 to 2025, saying claims rose from roughly $200 million to $14.4 billion. That 7,100% figure is a White House and Centers for Medicare & Medicaid Services (CMS) calculation presented at an administration briefing and has not been independently verified by this outlet or by non-administrative auditors.
Medicare transplant claims surge: What the administration says
Administration officials, including representatives of the White House Anti-Fraud Task Force, have said the dramatic spike in transplant-related billing prompted aggressive reviews, denials and enforcement. The administration presented the 2019-to-2025 comparison — from about $200 million to $14.4 billion — as evidence of widespread suspected improper billing.
CMS, which the administration says performed much of the claims review, told reporters it denied roughly 96% of claims submitted since March as part of its response. Vice President J.D. Vance and CMS officials are scheduled to speak at a news conference to outline additional steps.
Because the 7,100% figure and many headline numbers come from administration briefings and CMS statements, readers should treat the percentage as an administration-provided estimate pending independent audits or third-party confirmation.
Allegations on allografts and DME
CMS officials told reporters they flagged about 4,200 suspicious claims for allografts — donor tissue used in surgeries — with an estimated total of roughly $224 million through May. The administration characterized those filings as unusually large or inconsistent with clinical orders.
Officials also pointed to problems in the Durable Medical Equipment (DME) category, which covers wheelchairs, hospital beds, wound care supplies and related items. The administration says some suppliers billed for equipment that was not ordered or never delivered, billed for more complex items than clinicians ordered, or otherwise submitted questionable claims. These characterizations are framed by CMS and the White House as alleged improper billing until civil or criminal processes determine otherwise.
Federal enforcement and charges
CMS said it has suspended payments to 102 suppliers and revoked billing privileges for 725 providers tied to suspicious DME activity; the agency described suspended suppliers as representing about 8.6% of Medicare-funded DME in 2025. These actions, CMS officials say, are intended to stop potentially improper payments while audits and investigations proceed.
Separately, the Justice Department in May filed criminal charges in Minnesota against multiple individuals in a case the DOJ described as involving more than $90 million in allegedly fraudulent claims tied to state and federal assistance programs. Those prosecutions are ongoing and the allegations are subject to the legal process.
“In just six months, the task force has effectively wiped out Durable Medical Equipment fraud in America,” a spokesperson for Vice President Vance’s office told Fox News Digital, saying the work paired CMS reviews with DOJ enforcement.
Medicare transplant claims surge: impact on patients and taxpayers
The administration argues that if a meaningful portion of the reported increase is driven by fraudulent or improper billing, taxpayers could face substantial avoidable costs and Medicare solvency could be strained. Officials presented the $14.4 billion figure as total transplant-related claims volume for 2025 compared with about $200 million in 2019.
Patient advocates and providers caution that aggressive screening, broad suspensions or payment freezes can unintentionally delay access to needed equipment and surgical supplies for legitimate patients. CMS and task force officials say they are trying to target bad actors while preserving access, but public statements have offered limited detail on timely appeals, expedited reviews for urgent clinical needs, or explicit safeguards for patients dependent on DME or surgical allografts.
Because many of the administration’s numbers come from internal reviews, stakeholders including oversight groups and provider associations have called for independent audits or congressional oversight to verify the scale and causes of the spike.
What comes next
Vice President J.D. Vance and CMS Administrator Mehmet Oz are scheduled to appear at a news conference to discuss additional enforcement steps. Officials said the task force will continue coordinating with the Department of Justice and the Department of Health and Human Services to pursue civil audits and criminal referrals where evidence warrants.
Observers should expect more supplier suspensions, civil audits and potential criminal indictments tied to separate investigations. Enforcement in one jurisdiction, such as the Minnesota case handled by DOJ, demonstrates a path from audit to criminal prosecution, but each matter proceeds individually through its evidentiary and legal process.
FAQ
What does the 7,100% figure mean?
It is the administration’s comparison of reported Medicare tissue and organ transplant claims in 2025 versus 2019 (about $14.4 billion vs. about $200 million). That calculation comes from White House and CMS statements and has not been independently verified in public audits cited by this report.
Will patients lose access to transplants or DME?
CMS and the task force say they aim to block improper payments while preserving access. Patient groups warn that payment suspensions and denials can delay care; CMS has not released detailed public protocols for expedited reviews or appeals in every instance.
What penalties do suppliers face if found guilty?
Penalties can include suspension of Medicare payments, revocation of billing privileges, civil fines and criminal prosecution. Any specific penalties depend on the outcome of audits, civil proceedings and criminal trials.
Editor note: The two approved body images from the image plan will be added by the editorial team in the published CMS preview; they are not embedded in this draft.
Source reporting for this article is based on administration statements and reporting by Fox News Digital. The 7,100% figure and many related claims originate with the White House and CMS and have not been independently verified by this outlet.
Official sources and further reading: Fox News — Trump admin uncovers 7,100% surge in Medicare transplant claims, says anti-fraud crackdown blocked millions; CMS Newsroom; U.S. Department of Justice — Press Releases; White House Briefing Room.
